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SARS-CoV-2 or ‘COVID-19’
Amy M. Phillips, RN, BSN, PCCN
Otterbein University, Westerville, Ohio
Introduction
• The	novel	corona	virus	of	2019,	
commonly	referred	to	as	COVID-19
or	COVID,	was	first	reported	in	the	
Wuhan	province	of	China	in	
November	of	2019	and	rapidly	
spread	throughout	the	world	to	be	
declared	a	global	pandemic	by	the	
World	Health	Organization	(WHO)	
by	March	of	2020,	(CDC,	2020b).	
• COVID	belongs	to	a	common	family	
of	viruses	labelled	as	corona	
viruses	and	the	official	name	of	the	
COVID virus	is	Severe	Acute	
Respiratory	Distress	Syndrome	
Corona	Virus	2	or	SARS-CoV-2,	
(Ahmed	et	al.,	2020).
• Most	cases	(80%)	are	mild	and	
those	affected	have	been	able	to	
recover	at	home	without	needing	
hospital	care	or	treatment,	(WHO,	
2020).
• The	more	severe	cases	exhibit	an	
excessive	and	diffuse	inflammatory	
response	called	a	‘cytokine	storm’	
which	can	lead	to	multi-system	
organ	failure	(MSOF)	and	even	
death,	(Hellinger	et	al.,	2020;	
Picchianti	et	al.,	2020).
• COVID continues	to	show	
unpredictable	virulence,	and	the	
long-term	effects	of	those	with	
severe	COVID infections	are	still	yet	
to	be	identified,	(WHO,	2020).
(Ryback,	2020).
Pathophysiology
• COVID belongs	to	the	corona	virus	
(CoV)	family	which	is	a	large	family	
of	single-stranded	RNA	viruses	that	
can	be	isolated	from	various	animal	
species,	and	for	reasons	still	
unknown,	can	cross	the	species	
barrier,	causing	illness	in	humans	
ranging	from	the	common	cold	to	
more	severe	illnesses,	(Cascella	et	
al.,	2020).	
• CoV	viruses	have	shown	to	be	the	
primary	pathogen	responsible	for	
recent	respiratory	disease	
outbreaks	across	the	world	such	as	
the	SARS	outbreak	that	originated	
from	Asia	in	2003,	and	the	MERS	
outbreak	that	originated	in	Saudi	
Arabia	in	2012,	(Cascella	et	al.,	
2020;	CDC,	2017;	CDC,	2019).
• COVID-19 is	theorized	to	have	
originated	in	bats	but	has	yet	to	be	
determined.
• COVID	is	transmitted	similarly	to	
the	flu	and	rhinovirus,	through	
small,	heavy	respiratory	droplets	
from	the	nose	and	mouth	expelled	
by	coughing	and	sneezing,	(Cascella	
et	al.,	2020;	WHO,	2020).
• Aerosol	transmission	can	occur	in	
closed	spaces,	such	as	when	
performing	procedures	like	
intubation	and	bronchoscopies,	
(Cascella	et	al.,	2020).
• Respiratory	droplets	containing	COVID
fall	quickly	to	the	ground	and	can	be	
found	on	hard	surfaces	such	as	plastic	
and	metals	for	up	to	2-3	days,	(Cascella	
et	al.,	2020;	WHO,	2020).
• Incubation	period	ranges	from	3-7	
days	on	average,	with	a	median	of	
approximately	5	days	and	up	to	14	
days,	(Cascella	et	al.,	2020).	
• COVID shows	a	unique	affinity	for	
targeting	endothelial	cells	through	
angiotensin	converting	enzyme-2	
(ACE-2)	receptors,	which	can	be	found	
on	tissues	throughout	the	human	body,	
using	the	main	point	of	entry	as	the	
lungs	and	including	other	areas	such	as	
the	brain,	heart,	GI	tract,	kidneys	and	
vasculature	system,	(Ahmed	et	al.,	
2020;	Gamboa	et	al.,	2020;	Hellinger	et	
al.,	2020;	Matsushita	et	al.,	2020;	
Samanta	et	al.,	2020;	Sardu	et	al.,	2020;	
Stiwicki	et	al.,	2020).
• Serious	cases	of	COVID appear	to	
stimulate	an	excessive	immune	
reaction,	activating	a	cytokine-
mediated	immune	response	leading	to	
what	is	termed	a	cytokine	storm,	which	
activates	multiple	pro-inflammatory	
cytokines	causing	diffuse	tissue	
damage	and	dysfunctional	coagulation	
leading	to	MSOF	and	sometimes	even	
death,	(Cascella	et	al.,	2020;	Hellinger	
et	al.,	2020;	Picchianti	et	al.,	2020).
• Most	notable	cytokines	identified	so	far	
are	interleukin-6	(IL-6)-which	is	linked	
to	the	observed	high	fevers	and	MSOF,	
D-dimer,	C-reactive	proteins,	Ferritin,	
TNF-a	and	multiple	other	interleukins,	
(Cascella	et	al.,	2020;	Matsushita	et	al.,	
2020).
• This	diffuse	inflammatory	process	
produces	a	hypercoagulable	state	
causing	many	micro-emboli	that	
contribute	to	MSOF	seen	in	severe	
COVID cases,	and	clots	have	been	
discovered	in	almost	every	organ	on	
post-mortem	autopsies	of	COVID	
patients,	(Rapkiewicza	et	al.,	2020;	
Sardu	et	al.,	2020).
Significance of Pathophysiology
• With	the	lungs	and	respiratory	tract	
as	the	main	point	of	entry	for,	COVID
the	inflammatory	process	can	
produce	varying	levels	of	
pneumonia,	and	a	severe	
inflammatory	response	can	lead	to	
life	threatening	Acute	Respiratory	
Distress	Syndrome	(ARDS),	
requiring	mechanical	intubation	and	
extremely	aggressive	pulmonary	
measures	to	keep	the	body	and	vital	
organs	adequately	oxygenated	until	
recovery	is	obtained,	(Cascella	et	al.,	
2020;	Stawicki	et	al.,	2020).	
• Chest	imaging	such	as	x-ray	and	CT	
scans	tend	to	show	diffuse,	bilateral,	
ground-glass	opacities	despite	a	
diagnosis	of	pneumonia,	(Cascella	et	
al.,	2020;	Stawicki	et	al.,	2020).
• Severe	infections	can	lead	to	sepsis	
and	shock,	contributing	to	an	even	
higher	coagulable	state,	(Cascella	et	
al.,	2020).
• Due	to	COVID’s	nature	to	attack	
endothelial	cells,	inflammation	can	
cause	injury	to	many	other	organs,	
most	notably	the	brain,	heart,	GI	
tract,	kidneys	and	vascular	system.
• Brain	effects	include	encephalitis,	
viral	meningitis,	Guillain-Barre	
Syndrome	and	acute	cerebral	
vascular	disease	and	strokes,	
(Ahmed,	et	al.,	2020).	
(CDC,	2020a).
• Cardiac	effects	include	myocardial	
injury	(MI),	heart	failure	and	
arrythmia’s,	which	are	seen	mostly	in	
the	ICU	setting	versus	the	non-ICU	
setting	and	can	lead	to	mixed	forms	of	
shock	and	increase	the	risk	of	venous	
thromboembolism	(VTE)	(Matsushita	
et	al.,	2020).	
• Effects	on	the	GI	tract	can	vary	widely	
and	be	as	mild	as	diarrhea	as	a	result	
of	the	inflammation	in	the	colon	to	
hepatic	encephalopathy	or	hepatitis	as	
a	result	of	liver	dysfunction	or	failure,	
(Gamboa	et	al,	2020;	Hellinger	et	al.,	
2020;	Samanta	et	al.,	2020).
• Acute	Kidney	Injury	(AKI)	remains	
one	of	the	most	common	and	severe	
complications	seen	with	COVID,	often	
requiring	the	use	of	continuous	renal	
replacement	therapy	(CRRT)	to	
replace	the	normal	kidney	function	
until	recovery	is	established,	and	AKI	
contributes	to	a	higher	rate	of	
mortality	with	COVID,	(Sardu	et	al.,	
2020).
• One	of	the	most	profound	effects	of	
COVID is	the	formation	of	a	hyper-
coagulable	state	and	rate	of	micro-
venous-thromboses	or	clots,	despite	
full	anti-coagulation	with	medicine	
and	clots	have	been	found	throughout	
the	body,	including	the	brain,	heart,	
liver	and	kidneys,	on	those	patients	
whom	a	post-mortem	autopsy	was	
performed,	(Matsushita	et	al.,	2020;	
Rapkiewicza	et	al.,	2020;	Sardu	et	al.,	
2020).		
Signs & Symptoms
MOST	COMMONLY	SEEN
§ Fevers
§ Chills
§ Shortness	of	breath	or	difficulty	
breathing
§ Dry	Cough
§ Fatigue,	(CDC,	2020d;	WHO,	2020)
MILD	AND	LESS	COMMONLY	SEEN
§ Aches/Pains
§ Nasal	congestion
§ Headaches
§ Conjunctivitis
§ Sore	throat
§ Diarrhea
§ Loss	of	taste	and/or	smell
§ Rash	on	skin
§ Discoloration	of	fingers	and/or	toes
§ Nausea	
§ Vomiting,	(CDC,	2020d;	WHO,	
2020).
Treatment
There	is	no	current	cure	or	vaccine	
to	prevent	COVID-19.	
Prevention	of	COVID-19 is	the	
primary	focus	and	includes	measures	
such	as	frequent	hand	hygiene,	social	
distancing,	and	avoiding	touching	your	
face	and	mouth,	(Cascella	et	al.,	2020;	
WHO,	2020).
Most	cases	(~80%)	are	able	to	
recover	on	their	own	at	home,	but	the	
small	population	that	requires	medical	
attention	receive	supportive	care	such	
as	supplemental	oxygen	and	other	
aggressive	measures	used	in	shock	
states	and	organ	failure,	(Cascella	et	al.,	
2020;	Stawicki	et	al.,	2020;	WHO,	
2020).	
Currently,	there	are	many	
controversial	treatments	being	
researched:
• Corticosteroids	such	as	
Dexamethasone	has	shown	to	
decrease	death	by	1/3	in	recent	
RCT’s.
• Ant-virals	such	as	Remdesivir
• Anti-viral/Immunomodulators'	
such	as	Chloroquine,	
Hydroxychloroquine	along	with	
macrobids	like	Azithromycin	have	
been	used	to	help	decrease	viral	
load.
• Serotherapy	such	as	convalescent	
plasma	which	is	donated	by	
patients	who	have	recovered	from	
COVID-19	and	contains	protective	
anti-viral	antibodies	for	COVID.
• Inflammatory	inhibitors	to	block	
the	activation	of	macrophages	and	
T-cells	to	help	prevent/manage	
cytokine	storm,	(Cascella	et	al.,	
2020;	Picchianti	et	al.,	2020;	
Stawicki	et	al.,	2020).
Conclusion
The	ramifications	and	total	effects	of	
COVID-19	are	still	yet	to	be	determined,	
and	more	data	and	research	is	needed	
to	fully	understand	the	impact	that	this	
virus	will	have	on	the	world.	
The	long-term	effects	from	surviving	
this	virus	are	still	unknown,	and	as	
more	information	is	obtained,	new	
medical	practices	and	treatment	
strategies	will	evolve.
Implications for Nursing
Nurses	are	the	frontline	staff	delivering	direct	patient	care	in	times	of	pandemics	
and	are	frequently	at	risk	of	exposure	due	to	the	closeness	in	which	nurses	and	
patients	must	be	in,	in	order	to	provide	care.	Despite	a	feeling	of	professional	
obligation	to	care	for	people	during	a	pandemic,	nurses	may	feel	concerns	over	the	
personal	risks	this	entails,	such	as	the	personal	risk	of	infection,	transferring	
infection	to	family	members	and	risks	from	logistical	issues	associated	with	
insufficient	personal	protective	equipment	(PPE)	and	rapid	and	frequent	policy	
changes	to	accommodate	the	fluctuating	circumstances	throughout	a	pandemic,	
(Fernandez	et	al.,	2020).	Once	nurses	perceive	their	personal	risk	too	high,	they	may	
decide	to	leave	the	workforce,	creating	a	staffing	shortage,	contributing	to	the	
heightened	levels	of	stress	in	those	staff	that	decide	to	stay	at	the	bedside,	
(Fernandez	et	al.,	2020).	Frontline	staff	involved	in	pandemics	experience	stress	
associated	with	being	separated	from	their	family,	heavier	workloads,	staffing	
shortages,	continuous	policy	changes	and	moral	and	ethical	dilemmas	not	usually	
present	outside	of	pandemic	situations,	(Fernandez	et	al.,	2020).	Nurses	must	not	
only	balance	their	own	personal	stress	and	fears	associated	with	the	pandemic,	but	
also	experience	dealing	with	stress	from	their	co-workers	and	family	members	of	
patients	that	project	their	own	fears	and	frustrations	during	a	pandemic,	(Fernandez	
et	al.,	2020).	Nurses	must	also	deal	with	the	rapidly	evolving	and	changing	policies	
and	guidelines	that	may	create	confusion	and	again	increase	the	nurse’s	sense	of	
personal	risk	during	a	pandemic,	(Fernandez	et	al.,	2020).	Nurse’s	tend	to	be	
resilient	and	rely	on	each	other	to	help	each	other	out	in	times	of	need,	expressing	
experiences	comparable	to	those	of	being	on	a	battlefield,	(Fernandez	et	al.,	2020).	
Multi-faceted	approaches	should	be	utilized,	such	as	providing	clear	and	concise	
information	about	the	contagion	and	policy	changes,	maintaining	appropriate	PPE,	
providing	time	for	nurses	to	step	away	from	work	to	focus	on	necessary	family	
obligations	and	promoting	or	providing	opportunities	for	nurses	to	focus	on	their	
physical	and	mental	health	during	a	pandemic,	so	that	stress,	fatigue	and	burn-out	
can	be	prevented	to	help	avoid	a	critical	loss	of	nursing	in	the	workforce	during	a	
pandemic,	(Fernandez	et	al.,	2020).
(CDC,	2020c)References
